Silkway Impex accelerates China–Pakistan investment drive, signs agreements with leading Chinese enterprises

Silkway Impex has marked a highly productive month for its China–Pakistan investment program, signing cooperation agreements with four Chinese enterprises and widening its partnerships across manufacturing, infrastructure, real estate, healthcare, agriculture and advanced technology. The mission underlines the growing confidence of Chinese industrial groups — several of them substantial, publicly listed or Top 500-ranked businesses — in Pakistan as a destination for capital and capability.

The mission combined signed agreements, negotiations with major Chinese corporate groups and engagement with the Yunnan Belt and Road Information Service Center, leaving Silkway with a strong pipeline of projects to expand Pakistan's production base, introduce new technology and build export-capable businesses.

The delegation comprised Selman Pataudi, Managing Director International; Raja Taimur Rehman, Managing Director Pakistan; and Raja Hashim Rehman, Director of Operations.

"Pakistan is increasingly well placed to compete for the kind of investment that builds factories, develops skills and strengthens our capacity to produce and export," said Raja Taimur Rehman, Managing Director Pakistan, Silkway Impex. "We are bringing commercially credible opportunities to Chinese enterprises, building the partnerships needed to deliver them, and we look forward to turning this momentum into business on the ground."

Infrastructure and construction

At the Guizhou–Pakistan Economic and Trade Symposium on September 17, Silkway signed partnership agreements with four Guizhou-based enterprises, each bringing distinct capabilities.

Guizhou Bridge Construction Group brings considerable scale: a wholly state-owned enterprise holding the Special Grade Qualification for highway engineering construction, with registered capital of RMB 2.5 billion, total assets exceeding RMB 40 billion and an annual production capacity of more than RMB 15 billion.

Guizhou Theo Group, whose Light Weight Energy Saving Board subsidiary was among the signatories, has built more than a decade of expertise in energy-saving construction materials since formalizing operations in 2014. Guizhou Yingfeng Original Ecological Fertilizer Technology contributes strong agricultural innovation credentials — 39 patents and national high-tech enterprise status — with annual production and sales set to exceed 90,000 tons after a recent capacity expansion.

Together with Guizhou Huarong Group, these agreements give Silkway a well-rounded platform spanning transport infrastructure, energy-efficient building materials, fertilizer technology and integrated poultry production — sectors aligned with Pakistan's infrastructure, construction and food-security priorities.

Real estate

The delegation met Nantong Yuxianghong Construction Group on the final day of the visit to confirm investment details under a previously signed agreement, adding a dedicated property development relationship to Silkway's construction and infrastructure program.

Healthcare

Healthcare proved a particularly strong theme. Following discussions on 22 September, Haisco Pharmaceutical Group — a Shenzhen Stock Exchange-listed group (SZSE: 002653) — expressed strong interest in partnering with Silkway to develop its brand and market products in Pakistan. Haisco is a substantial, fast-growing business, with operating revenue of RMB 4.388 billion for 2025 (up 17.91 per cent year-on-year) and five modern pharmaceutical manufacturing bases across Liaoning, Sichuan and Tibet, employing more than 6,000 people, including nearly 1,000 in research and development.

The proposed relationship would combine this manufacturing and R&D base with Silkway's local market development and commercial execution capability, with product introduction subject to approvals and final commercial arrangements.

The healthcare program extended further through meetings with Yunnan Phytopharmaceutical and MagFlare. Yunnan Phytopharmaceutical, a wholly-owned subsidiary of Yunnan Pharmaceutical Industry Co., Ltd. with research roots dating to the 1960s, holds National Drug Approval Numbers for 121 products and specializes in botanical formulations built around Panax notoginseng and Erigeron breviscapus — two of Yunnan's signature medicinal plants — adding deep expertise to Silkway's healthcare pipeline.

Manufacturing and advanced technology

Silkway also held encouraging discussions with China Boton Group (HKEX: 3318), which became the first Chinese flavour and fragrance enterprise to list on the Hong Kong Stock Exchange Main Board in 2005 and reported operating revenue of RMB 1.653 billion in 2024.

Discussions with Shenlong Steel — part of Guangxi Shenglong Metallurgy Co., Ltd., ranked 87th on the 2025 China Top 500 Private Enterprises list with revenue of RMB 111.3 billion — focused on developing its Pakistan market presence and serving local industrial demand, drawing on an annual capacity of 1.25 million tons across galvanized, aluminum-zinc and zinc-aluminum-magnesium products.

The delegation's visit to Yunnan Hudian examined drone manufacturing, communications and emergency-response capabilities, aiming to identify commercial applications in Pakistan and a pathway to local technical capability, technology transfer and localization.

Government engagement

The mission concluded with a warm exchange with Zhang Yibing, Secretary-General of the Yunnan Belt and Road Information Service Center, and Standing Committee representatives, covering Yunnan's policy support for Belt and Road cooperation, Pakistan's import and export requirements, and the coordination channels needed to deliver these opportunities.

"Execution will determine the value of this program," Rehman added. "Our priority is to select the strongest opportunities, establish the commercial case and put clear responsibility behind delivery. We want these relationships to produce businesses that invest, employ and grow in Pakistan for years to come."

Silkway is now advancing these engagements through project selection, feasibility assessment and commercial structuring with prospective partners. Joint ventures, local manufacturing and technology transfer remain central to the models under evaluation, with projects progressing as terms and implementation requirements are agreed.